These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15359582)

  • 41. Regional oral absorption, hepatic first-pass effect, and non-linear disposition of salmon calcitonin in beagle dogs.
    Hee Lee Y; Leesman GD; Makhey V; Yu H; Hu P; Perry B; Sutyak JP; Wagner EJ; Falzone LM; Stern W; Sinko PJ
    Eur J Pharm Biopharm; 2000 Sep; 50(2):205-11. PubMed ID: 10962228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extrahepatic first-pass metabolism of nifedipine in the rat.
    Grundy JS; Eliot LA; Foster RT
    Biopharm Drug Dispos; 1997 Aug; 18(6):509-22. PubMed ID: 9267683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.
    Chesa-Jiménez J; Peris JE; Torres-Molina F; Granero L
    Antimicrob Agents Chemother; 1994 Apr; 38(4):842-7. PubMed ID: 8031056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo disposition and in vitro metabolism of an anxiolytic compound, BMS-184111, in rats.
    Yeleswaram K; Volk KJ; Rourick R; Catt JD; Mattson RJ; McGoff KB; Knipe JO
    Res Commun Mol Pathol Pharmacol; 1995 Jul; 89(1):27-44. PubMed ID: 7582859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of inflammation and proadifen on the disposition of antipyrine, lignocaine and propranolol in rat isolated perfused liver.
    Chindavijak B; Belpaire FM; Bogaert MG
    J Pharm Pharmacol; 1987 Dec; 39(12):997-1002. PubMed ID: 2894448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-pass metabolism of omeprazole in rats.
    Watanabe K; Furuno K; Eto K; Oishi R; Gomita Y
    J Pharm Sci; 1994 Aug; 83(8):1131-4. PubMed ID: 7983597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of intestinal and hepatic first-pass extraction on the pharmacokinetics of everolimus in rats.
    Yokomasu A; Yano I; Sato E; Masuda S; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2008; 23(6):469-75. PubMed ID: 19122342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A priming dose of propranolol reduces the availability of a subsequent dose in the isolated perfused rat liver preparation.
    Ghabrial H; Sewell RB; Smallwood RA; Morgan DJ
    Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):110-3. PubMed ID: 9493498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First-pass metabolism of 5-fluorouracil in rats.
    Yuasa H; Gu J; Hayashi Y; Watanabe J
    J Pharm Pharmacol; 1998 Sep; 50(9):1019-25. PubMed ID: 9811163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model.
    Wang SJ; Zeng J; Yang BK; Zhong YM
    Pharm Biol; 2014 Sep; 52(9):1150-7. PubMed ID: 24635458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism.
    Orrego-Lagarón N; Martínez-Huélamo M; Vallverdú-Queralt A; Lamuela-Raventos RM; Escribano-Ferrer E
    Br J Nutr; 2015 Jul; 114(2):169-80. PubMed ID: 26083965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
    Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
    Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Product inhibition and dose-dependent bioavailability of propranolol in the isolated perfused rat liver preparation.
    Ghabrial H; Nand R; Stead CK; Smallwood RA; Morgan DJ
    J Pharm Sci; 1994 Jul; 83(7):931-6. PubMed ID: 7965671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid-phase extraction and ultra high-performance liquid chromatography tandem mass spectrometry analysis of the gastrointestinal absorption of emodin in different digestive segments of rats.
    Kong W; Xia X; Wang J; Zhou C; Fang F; Xing X; Jin C; Zhao Y; Zang Q; Xiao X
    J Sep Sci; 2011 Feb; 34(3):260-7. PubMed ID: 21268248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences of first-pass effect in the liver and intestine contribute to the stereoselective pharmacokinetics of rhynchophylline and isorhynchophylline epimers in rats.
    Wang X; Zheng M; Liu J; Huang Z; Bai Y; Ren Z; Wang Z; Tian Y; Qiao Z; Liu W; Feng F
    J Ethnopharmacol; 2017 Sep; 209():175-183. PubMed ID: 28755970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating the bioavailabilities of olerciamide A via the rat's hepatic, gastric and intestinal first-pass effect models.
    Zhao C; Ying Z; Hao D; Zhang W; Ying X; Yang G
    Biopharm Drug Dispos; 2019 Apr; 40(3-4):112-120. PubMed ID: 30739353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic, gastric and intestinal first-pass effects of vitexin-2''-O-rhamnoside in rats by ultra-high-performance liquid chromatography.
    Gao Y; Du Y; Ying Z; Leng A; Zhang W; Meng Y; Li C; Xu L; Ying X; Kang T
    Biomed Chromatogr; 2016 Feb; 30(2):111-6. PubMed ID: 26031900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. I. Possible factors for the low oral bioavailability in rats.
    Sasaki I; Fujita T; Murakami M; Yamamoto A; Nakamura E; Imasaki H; Muranishi S
    Biol Pharm Bull; 1994 Sep; 17(9):1256-61. PubMed ID: 7841949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.